FDA Approves Kamada Plasma Collection Center in San Antonio, Texas for Commercial Sales of Normal Source Plasma
ByAinvest
Thursday, Mar 26, 2026 7:01 am ET1min read
KMDA--
Kamada's plasma collection center in San Antonio, TX, has been approved by the FDA. The center, with an annual capacity of 50,000 liters, is expected to generate $8-10 million in annual revenue. The facility is structured to collect normal source plasma and specialty plasma, making it one of the largest centers for specialty plasma collection in the US. Kamada plans to seek EMA approval and expects the center to commence commercial sales of normal source plasma.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet